What the Future Holds for Hair Loss Sufferers

Men have been seeking an ultimate cure for baldness for ages but until quite recently all available remedies were either cosmetic cover-ups or vitamin/mineral pills and herbal lotions, with too many of them just being scams. It was only with the advent of finasteride and minoxidil and improvements made in hair transplantation techniques in recent years that the new era began, enabling hair loss sufferers to halt the further progression of the balding process and replace the missing hair on top of their head using the hair left at the back of their scalp. However, to this day no ultimate cure for baldness exists. Nevertheless, there are presently several promising drugs and new techniques under development but none of these new therapies is expected to hit the market before 2015.

To start with, NEOSH101 is being developed by the US firm Neosil and it is currently undergoing phase IIb clinical testing. NEOSH101 has been proven to be a more powerful and faster-acting hair growth stimulant than minoxidil while it only needs applying once daily. Though significantly improving the current hair loss treatment options, NEOSH101 is not going to become an ultimate cure for baldness. The clinical trials seem to be advancing slower than most hair loss sufferers would like and, therefore, do not hold your breath for it hitting the market anytime soon. NEOSH101 is mainly expected to replace minoxidil and other existing hair growth stimulants.

Another promising line of development seems to be the telomerase research. Telomerase is an enzyme that is said to able to put natural caps on telomeres and thus protect them from shortening. Telomerase thereby maintains the genomic integrity. Shortened telomeres are associated with the premature aging processes. However, the uncontrolled activation of telomerase can cause cancer. Cancer research happens to be the main focus of the telomerase study but scientists are also looking for other applications, such as anti-aging drugs and drugs against hair loss and grey hair. Although still under development, there are already some products available on the market that seek to emulate the mechanism of telomerase action but they have no scientific backing and should better be avoided. Telomerase research could really change the world of medicine but its commercial application might be a good decade away.

Hair multiplication, often called hair cloning or follicular neogenesis, is the next hopeful treatment option being currently developed. This technique involves extracting the hair follicles from the back of the patient’s scalp, culturing and multiplying them and injecting the newly-grown hair cells into the bald scalp. Among several teams of scientists on three continents researching hair multiplication, the UK healthcare firm Intercytex appears to be the frontrunner. However, Intercytex is currently facing financial difficulties and is looking to sign-up a partner, which can delay the development process. This therapy might hit the market in 2013 at the earliest. The main benefit of hair multiplication would be solving the chronic shortage of donor hair that is the main limiting factor in hair transplantation.

Generating hair follicles in hair-free skin wounds is an utterly new approach to regrowing hair. It was discovered accidentally as wounded skin in mice started growing new hair. This technology is currently being developed by the US medical device company, Follica that licensed this technology from the University of Pennsylvania. Though this method may sound weird it only uses common instruments and drugs that have already been medically approved and thus it might not take too long for it to become available to the public.

This is the list of only a few promising treatments for hair loss that are being currently developed but many others seem to be in the pipeline. It appears that becoming bald will soon be by choice rather than destiny.